Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|May 3, 2014
HIV-2 viral tropism influences CD4+ T cell count regardless of viral loadAna Treviño, Vicente Soriano, Eva Poveda, et al.
Sexually Transmitted Infections|August 6, 2020
Screening for asymptomatic STIs in HIV-infected men who have sex with menRein Willekens, Irene Sánchez, Lucía Miguel, et al.
AIDS (London, England)|July 31, 2012
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapiesLourdes Anta, Josep M Llibre, Eva Poveda, et al.
Journal of Medical Virology|April 19, 2005
Infection with human T lymphotropic virus type I in organ transplant donors and recipients in SpainCarlos Toro, Rafael Benito, Antonio Aguilera, et al.
AIDS (London, England)|August 3, 2019
Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in SpainSilvia Requena, Estrella Caballero, Ana Belén Lozano, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 2007
Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistanceCarmen de Mendoza, Carmen Rodriguez, Federico García, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|May 13, 2026
Prognostic value of radionics based on 18F-FDG PET/CT in Hodgkin lymphoma: a systematic reviewClémentine Pradère, Jorge Mucientes Rasilla, Belén Navarro Matilla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 6, 2009
Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infectionArkaitz Imaz, Sara Villar del Saz, M Angels Ribas, et al.
AIDS (London, England)|March 31, 2017
HIV type 2 epidemic in Spain: challenges and missing opportunitiesCarmen de Mendoza, Teresa Cabezas, Estrella Caballero, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2010
Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretroviralsArkaitz Imaz, Josep M Llibre, Marta Mora, et al.
Pageof 5